BioStem Technologies (OTC: BSEM)’s cover photo
BioStem Technologies (OTC: BSEM)

BioStem Technologies (OTC: BSEM)

Biotechnology

Pompano Beach, FL 2,582 followers

We Manufacture Products That Change Lives

About us

BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioRetain processing method. BioRetain has been developed by applying the latest research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. BioStem Technologies' quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks ("AATB"). These systems and procedures are established per current Good Tissue Practices ("cGTP") and current Good Manufacturing Processes ("cGMP"). Our portfolio of quality brands includes VENDAJE, VENDAJE AC, and VENDAJE OPTIC. Each BioStem Technologies placental allograft is processed at the Company's FDA registered and AATB accredited site in Pompano Beach, Florida.

Website
http://www.biostemtechnologies.com
Industry
Biotechnology
Company size
11-50 employees
Headquarters
Pompano Beach, FL
Type
Public Company
Founded
2014
Specialties
Biotechnology, Stem Cell Therapy, and Regenerative Medicine

Locations

Employees at BioStem Technologies (OTC: BSEM)

Updates

Similar pages

Browse jobs

Funding